Discriminating a common somatic ASXL1 mutation (c.1934dup; p.G646Wfs*12) from artifact in myeloid malignancies using NGS

Leukemia. 2018 Aug;32(8):1874-1878. doi: 10.1038/s41375-018-0193-y. Epub 2018 Jun 29.

Michael O Alberti¹, Sridhar Nonavinkere Srivatsan², Jin Shao², Samantha N McNulty¹, Gue Su Chang^{2

3}, Christopher A Miller^{2

3}, Jennifer B Dunlap⁴, Fei Yang^{4

5}, Richard D Press^{4

5}, Qingsong Gao^{2

3}, Li Ding^{2

3

6

7}, Jonathan W Heusel¹, Eric J Duncavage¹, Matthew J Walter^{8

9}

¹ Department of Pathology & Immunology, Washington University School of Medicine, St. Louis, MO, USA.
² Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA.
³ McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
⁴ Department of Pathology, Oregon Health & Science University, Portland, OR, USA.
⁵ Knight Cancer Institute, Oregon Health & Science University, Portland, OR, USA.
⁶ Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
⁷ Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA.
⁸ Division of Oncology, Department of Internal Medicine, Washington University School of Medicine, St. Louis, MO, USA. mjwalter@wustl.edu.
⁹ Siteman Cancer Center, Washington University School of Medicine, St. Louis, MO, USA. mjwalter@wustl.edu.

No abstract available

Publication types